The final point made, i.e., a more powerful capitalized company with a better science and all that that implies, is so very crucial for investors to consider.
We have an unending sinking share price, with the promise of more of the same to come, given continuing dilution and discouragement, imo, From my investing perspective,fwiw as everyone thinks and feels differently, get what is available and be thankful and consider re-entering when/if clinicals show true promise, with the keen recognition that even under that scenario, one's investment is talking years and years to materialize.
News 
Market Data 
Discover 
AI
